Bennett Lawrence Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-35,812
Closed -$11.8M 107
2014
Q1
$11.8M Buy
+35,812
New +$12.1M 1.75% 20

Other funds holding ICPT

Bennett Lawrence Management's ICPT Position: Q2 2014 in Review

Bennett Lawrence Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2014, closing a stake of 35,812 shares — an estimated $11.8M sold.

Bennett Lawrence Management first reported a position in ICPT in Q1 2014 and held it in 1 quarter. The position peaked at $11.8M in Q1 2014. 167 funds tracked by Wall St. Rank hold ICPT as of Q2 2014.

  • Bennett Lawrence Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Bennett Lawrence Management sold 35,812 Intercept Pharmaceuticals, Inc. shares in Q2 2014, an estimated $11.8M.
  • Bennett Lawrence Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 1 quarter.
  • Bennett Lawrence Management's Intercept Pharmaceuticals, Inc. position peaked at $11.8M in Q1 2014.
  • 167 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2014.

Based on Bennett Lawrence Management's 13F filing for Q2 2014, filed 6 Aug 2014.